Ignite Creation Date:
2024-05-06 @ 3:52 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04798677
Status:
COMPLETED
Last Update Posted:
2022-07-21
First Post:
2021-03-12
Brief Title:
Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine
Sponsor:
AB Biotek
Organization:
AB Biotek
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-29
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-09-24
Completion Date Type:
ACTUAL
First Submit Date:
2021-03-12
First Submit QC Date:
March 12 2021
Study First Post Date:
2021-03-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-07-19
Last Update Post Date:
2022-07-21
Last Update Post Date Type:
ACTUAL